Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD4 CD44-CD62L+ NKT cells
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD4 CD44-CD62L+ NKT cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / Neutrophils
|
HET
|
1f:3m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / Neutrophils
|
HOM
|
2f:m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Hematology / Platelet count
|
HOM
|
5f:1m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0196
|
Successful |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Hematology / Platelet count
|
HET
|
10f:10m
|
Linear Mixed Model framework, LME, including Weight
|
0.0242
|
Successful |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD8 T cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD8 T cells
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / Monocytes
|
HOM
|
2f:m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / Monocytes
|
HET
|
1f:3m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD8 CD44-CD62L+ T cells
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD8 CD44-CD62L+ T cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD8 CD44+CD62L- NKT cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD8 CD44+CD62L- NKT cells
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / DN CD25+ T cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / DN CD25+ T cells
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Hematology / Mean cell hemoglobin concentration
|
HET
|
10f:10m
|
Linear Mixed Model framework, LME, including Weight
|
0.0125
|
Successful |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Hematology / Mean cell hemoglobin concentration
|
HOM
|
5f:1m
|
Linear Mixed Model framework, LME, not including Weight
|
0.904
|
Successful |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / Transitional B Cells (CD21/35 low)
|
HOM
|
2f:m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / Transitional B Cells (CD21/35 low)
|
HET
|
1f:3m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / Eosinophils
|
HOM
|
2f:m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / Eosinophils
|
HET
|
1f:3m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / DN T cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / DN T cells
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD8 CD44-CD62L- T cells
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD8 CD44-CD62L- T cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / DN CD44+CD62L- T cells
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / DN CD44+CD62L- T cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / T Cells (panel B)
|
HET
|
1f:3m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / T Cells (panel B)
|
HOM
|
2f:m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / Follicular B Cells
|
HET
|
1f:3m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / Follicular B Cells
|
HOM
|
2f:m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / DN CD25- T cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / DN CD25- T cells
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / NK Cells (panel B)
|
HET
|
1f:3m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / NK Cells (panel B)
|
HOM
|
2f:m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Hematology / Mean platelet volume
|
HET
|
10f:10m
|
Linear Mixed Model framework, LME, including Weight
|
0.276
|
Successful |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Hematology / Mean platelet volume
|
HOM
|
5f:1m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.384
|
Successful |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD4 CD44+CD62L- NKT cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD4 CD44+CD62L- NKT cells
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Hematology / Mean corpuscular hemoglobin
|
HOM
|
5f:1m
|
Linear Mixed Model framework, LME, including Weight
|
0.155
|
Successful |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Hematology / Mean corpuscular hemoglobin
|
HET
|
10f:10m
|
Linear Mixed Model framework, LME, not including Weight
|
0.280
|
Successful |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / DP T cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / DP T cells
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD8 CD25- NKT cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD8 CD25- NKT cells
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / NKT Subsets (Q3)
|
HOM
|
2f:m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / NKT Subsets (Q3)
|
HET
|
1f:3m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / DN CD25+ NKT cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / DN CD25+ NKT cells
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / Follicular B Cells (CD21/35+)
|
HET
|
1f:3m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / Follicular B Cells (CD21/35+)
|
HOM
|
2f:m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD4 NKT cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD4 NKT cells
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD4 CD44+CD62L+ NKT cells
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD4 CD44+CD62L+ NKT cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / NK Subsets (Q1)
|
HET
|
1f:3m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / NK Subsets (Q1)
|
HOM
|
2f:m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Hematology / Mean cell volume
|
HOM
|
5f:1m
|
Linear Mixed Model framework, LME, including Weight
|
0.205
|
Successful |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Hematology / Mean cell volume
|
HET
|
10f:10m
|
Linear Mixed Model framework, LME, including Weight
|
0.696
|
Successful |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD4 T cells
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD4 T cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / DN CD44+CD62L+ T cells
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / DN CD44+CD62L+ T cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / cDCs
|
HET
|
1f:3m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / cDCs
|
HOM
|
2f:m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD8 NKT cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD8 NKT cells
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Hematology / Hemoglobin
|
HET
|
10f:10m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0458
|
Successful |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Hematology / Hemoglobin
|
HOM
|
5f:1m
|
Linear Mixed Model framework, LME, not including Weight
|
0.250
|
Successful |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / NKT cells (panel A)
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / NKT cells (panel A)
|
HET
|
3f:3m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / NK Subsets (Q2)
|
HET
|
1f:3m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / NK Subsets (Q2)
|
HOM
|
2f:m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / DN CD44-CD62L+ T cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / DN CD44-CD62L+ T cells
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / MZB (CD21/35 high)
|
HET
|
1f:3m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / MZB (CD21/35 high)
|
HOM
|
2f:m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / B1B Cells
|
HOM
|
2f:m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / B1B Cells
|
HET
|
1f:3m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / DN CD44+CD62L+ NKT cells
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / DN CD44+CD62L+ NKT cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Hematology / Red blood cell count
|
HET
|
10f:10m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0791
|
Successful |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Hematology / Red blood cell count
|
HOM
|
5f:1m
|
Linear Mixed Model framework, LME, not including Weight
|
0.390
|
Successful |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / cDCs CD11b Type
|
HOM
|
2f:m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / cDCs CD11b Type
|
HET
|
1f:3m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / DN CD44-CD62L+ NKT cells
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / DN CD44-CD62L+ NKT cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Clinical Chemistry / LIH (Hemolysis Severity - available on AU analysers)
|
HET
|
10f:10m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Clinical Chemistry / LIH (Hemolysis Severity - available on AU analysers)
|
HOM
|
5f:1m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / NK cells (panel A)
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / NK cells (panel A)
|
HET
|
3f:3m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD4 CD44-CD62L+ T cells
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD4 CD44-CD62L+ T cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Hematology / Hematocrit
|
HET
|
10f:10m
|
Linear Mixed Model framework, LME, not including Weight
|
0.215
|
Successful |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Hematology / Hematocrit
|
HOM
|
5f:1m
|
Linear Mixed Model framework, LME, not including Weight
|
0.301
|
Successful |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / B2B Cells
|
HOM
|
2f:m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / B2B Cells
|
HET
|
1f:3m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / NK Subsets (Q3)
|
HET
|
1f:3m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / NK Subsets (Q3)
|
HOM
|
2f:m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / DN NKT cells
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / DN NKT cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / NK Subsets (Q4)
|
HOM
|
2f:m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / NK Subsets (Q4)
|
HET
|
1f:3m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / DN CD44-CD62L- T cells
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / DN CD44-CD62L- T cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD8 CD25+ NKT cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD8 CD25+ NKT cells
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / pDCs
|
HOM
|
2f:m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / pDCs
|
HET
|
1f:3m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Hematology / Red blood cell distribution width
|
HOM
|
5f:1m
|
Linear Mixed Model framework, LME, not including Weight
|
|
Successful |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Hematology / Red blood cell distribution width
|
HET
|
10f:10m
|
Linear Mixed Model framework, LME, including Weight
|
0.243
|
Successful |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD4 CD44-CD62L- T cells
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD4 CD44-CD62L- T cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD8 CD44+CD62L+ NKT cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD8 CD44+CD62L+ NKT cells
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD4 CD44+CD62L- T cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD4 CD44+CD62L- T cells
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD4 CD25+ T cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD4 CD25+ T cells
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD4 CD25- T cells
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD4 CD25- T cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / NKT Cells (panel B)
|
HET
|
1f:3m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / NKT Cells (panel B)
|
HOM
|
2f:m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD8 CD44-CD62L+ NKT cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD8 CD44-CD62L+ NKT cells
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD8 CD44+CD62L- T cells
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD8 CD44+CD62L- T cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / T Subset
|
HOM
|
2f:m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / T Subset
|
HET
|
1f:3m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / NKT Subsets (Q1)
|
HOM
|
2f:m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / NKT Subsets (Q1)
|
HET
|
1f:3m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD8 CD25+ T cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD8 CD25+ T cells
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD4 CD44+CD62L+ T cells
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD4 CD44+CD62L+ T cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD8 CD44+CD62L+ T cells
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD8 CD44+CD62L+ T cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / T cells (panel A)
|
HET
|
3f:3m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / T cells (panel A)
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / RP Macrophage (CD19- CD11c-)
|
HET
|
1f:3m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / RP Macrophage (CD19- CD11c-)
|
HOM
|
2f:m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / DN CD44+CD62L- NKT cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / DN CD44+CD62L- NKT cells
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / B Cells
|
HOM
|
2f:m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / B Cells
|
HET
|
1f:3m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD4 CD25+ NKT cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD4 CD25+ NKT cells
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Hematology / White blood cell count
|
HOM
|
5f:1m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0554
|
Successful |
Zfp445tm1b(EUCOMM)Hmgu
|
HMGU
|
Hematology / White blood cell count
|
HET
|
10f:10m
|
Linear Mixed Model framework, LME, not including Weight
|
0.168
|
Successful |